Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'AF-DX 116' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 57 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hata, T; Itoh, E; Funakami, Y; Ishida, K; Uchida, S
      Blood pressure and heart rate are increased by AF-DX 116, a selective M-2 antagonist, in autonomic imbalanced and hypotensive rats caused by repeatedcold stress

      JAPANESE JOURNAL OF PHARMACOLOGY
    2. Lanzafame, A; Christopoulos, A; Mitchelson, F
      The allosteric interaction of otenzepad (AF-DX 116) at muscarinic M-2 receptors in guinea pig atria

      EUROPEAN JOURNAL OF PHARMACOLOGY
    3. Cook, AK; Carty, M; Singer, CA; Yamboliev, IA; Gerthoffer, WT
      Coupling of M-2 muscarinic receptors to ERK MAP kinases and caldesmon phosphorylation in colonic smooth muscle

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    4. Ellis, J; Seidenberg, M
      Site-directed mutagenesis implicates a threonine residue in TM6 in the subtype selectivities of UH-AH 37 and pirenzepine at muscarinic receptors

      PHARMACOLOGY
    5. Stengel, PW; Gomeza, J; Wess, J; Cohen, ML
      M-2 and M-4 receptor knockout mice: Muscarinic receptor function in cardiac and smooth muscle in vitro

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    6. Coelho, JE; de Mendonca, A; Ribeiro, JA
      Presynaptic inhibitory receptors mediate the depression of synaptic transmission upon hypoxia in rat hippocampal slices

      BRAIN RESEARCH
    7. Cohen, VI; Jin, BY; McRee, RC; Boulay, SF; Cohen, EI; Sood, VK; Zeeberg, BR; Reba, RC
      In vitro and in vivo m2 muscarinic subtype selectivity of some dibenzodiazepinones and pyridobenzodiazepinones

      BRAIN RESEARCH
    8. Sasaki, S; Motomura, S
      Comparison of anti-M2-muscarinic effect of AF-DX 116 on atrioventricular nodal conduction with those of pirenzepine and atropine as antibradyarrhythmic drugs

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    9. Yono, M; Yoshida, M; Wada, Y; Kikukawa, H; Takahashi, W; Inadome, A; Seshita, H; Ueda, S
      Pharmacological effects of tolterodine on human isolated urinary bladder

      EUROPEAN JOURNAL OF PHARMACOLOGY
    10. KOPF SR; BOCCIA MM; BARATTI CM
      AF-DX-116, A PRESYNAPTIC MUSCARINIC RECEPTOR ANTAGONIST, POTENTIATES THE EFFECTS OF GLUCOSE AND REVERSES THE EFFECTS OF INSULIN ON MEMORY

      Neurobiology of learning and memory (Print)
    11. NAITO H; FURUKAWA Y; HASHIMOTO K
      EFFECTS OF A CARDIOSELECTIVE M-2 RECEPTOR ANTAGONIST, AF-DX-116, ON VENTRICULAR ARRHYTHMIAS IN DOGS

      Heart and vessels
    12. BALAIS SYH; PRADO WA; ALVESDOPRADO W
      ANTAGONISTIC EFFECTS OF TRIFLUOPERAZINE, IMIPRAMINE, AND CHLORPROMAZINE AGAINST ACETYLCHOLINE-INDUCED CONTRACTIONS IN ISOLATED RAT UTERUS

      Zhongguo yaoli xuebao
    13. KOSS MC
      FUNCTIONAL-CHARACTERIZATION OF PERIPHERAL MUSCARINIC SUBTYPES IN ANESTHETIZED CATS

      Life sciences
    14. WATANABE T; KINOYAMA I; KAKEFUDA A; OKAZAKI T; TAKIZAWA K; HIRANO S; SHIBATA H; YANAGISAWA I
      SYNTHESIS OF NOVEL SUCCINAMIDE DERIVATIVES HAVING THE 1-DIHYDRO-6H-PYRIDO[2,3-B][1,4]BENZODIAZEPIN-6-ONE SKELETON AS POTENT AND SELECTIVE M-2 MUSCARINIC RECEPTOR ANTAGONISTS .1.

      Chemical and Pharmaceutical Bulletin
    15. BELMONTE KE; JACOBY DB; FRYER AD
      INCREASED FUNCTION OF INHIBITORY NEURONAL M-2 MUSCARINIC RECEPTORS INDIABETIC RAT LUNGS

      British Journal of Pharmacology
    16. ASLAN N; GOREN Z; OZKUTLU U; ONAT F; OKTAY S
      MODULATION OF THE PRESSOR-RESPONSE ELICITED BY CARBACHOL AND ELECTRICAL-STIMULATION OF THE AMYGDALA BY MUSCARINIC ANTAGONISTS IN CONSCIOUS RATS

      British Journal of Pharmacology
    17. MICKALA P; BOUTIN H; BELLANGER C; CHEVALIER C; MACKENZIE ET; DAUPHIN F
      IN-VIVO BINDING, PHARMACOKINETICS AND METABOLISM OF THE SELECTIVE M(2) MUSCARINIC ANTAGONISTS [H-3]AF-DX-116 AND [H-3]AF-DX-184 IN THE ANESTHETIZED RAT

      Nuclear medicine and biology
    18. OHNUKI T; NOMURA Y
      EFFECTS OF SELECTIVE MUSCARINIC ANTAGONISTS, PIRENZEPINE AND AF-DX116, ON PASSIVE-AVOIDANCE TASKS IN MICE

      Biological & pharmaceutical bulletin
    19. STRIJCKMANS V; COULON C; KASSIOU M; LOCH C; MAZIERE B
      IN-VITRO PHARMACOLOGICAL PROPERTIES OF 4-BROMODEXETIMIDE FOR MUSCARINIC RECEPTORS

      Life sciences
    20. SVENSSON AL; ZHANG X; NORDBERG A
      BIPHASIC EFFECT OF TACRINE ON ACETYLCHOLINE-RELEASE IN RAT-BRAIN VIA M(1) AND M(2) RECEPTORS

      Brain research
    21. AMENTA F; LIU A; GIANNELLA M; PIGINI M; TAYEBATI SK; ZACCHEO D
      AGE-RELATED-CHANGES IN THE DENSITY OF MUSCARINIC CHOLINERGIC M(1) ANDM(2) RECEPTOR SUBTYPES IN PYRAMIDAL NEURONS OF THE RAT HIPPOCAMPUS

      European journal of histochemistry
    22. DRINKENBURG WHIM; SONDAG HNPM; COENDERS CJH; ANDREWS JS; VOSSEN JMH
      EFFECTS OF SELECTIVE ANTAGONISM OR DEPLETION OF THE CHOLINERGIC SYSTEM ON VISUAL-DISCRIMINATION PERFORMANCE IN RATS

      Behavioural pharmacology
    23. VANZWIETEN PA; DOODS HN
      MUSCARINIC RECEPTORS AND DRUGS IN CARDIOVASCULAR MEDICINE

      Cardiovascular drugs and therapy
    24. LEJEUNE H; AUBERT I; JOURDAN F; QUIRION R
      COMPARATIVE LAMINAR DISTRIBUTION OF VARIOUS AUTORADIOGRAPHIC CHOLINERGIC MARKERS IN ADULT-RAT MAIN OLFACTORY-BULB

      Journal of chemical neuroanatomy
    25. MIRANDA HF; DURAN E; FERNANDEZ E; PINARDI G
      MUSCARINIC RECEPTOR SUBTYPES IN THE BISECTED VAS-DEFERENS OF THE RAT

      General pharmacology
    26. LEVEY AI; EDMUNDS SM; KOLIATSOS V; WILEY RG; HEILMAN CJ
      EXPRESSION OF M1-M4 MUSCARINIC ACETYLCHOLINE-RECEPTOR PROTEINS IN RATHIPPOCAMPUS AND REGULATION BY CHOLINERGIC INNERVATION

      The Journal of neuroscience
    27. CANDURA SM; TONINI M; BAIARDI P; MANZO L; COSTA LG
      HETEROGENEITY OF CHOLINERGIC MUSCARINIC RECEPTORS COUPLED TO PHOSPHOINOSITIDE METABOLISM IN IMMATURE RAT-BRAIN

      Developmental brain research
    28. HORI H; HARUTA K; NANKI M; SAKAMOTO N; UEMURA K; MATSUBARA T; ITOH K; IGUCHI A
      PRESSOR-RESPONSE INDUCED BY THE HIPPOCAMPAL ADMINISTRATION OF NEOSTIGMINE IS SUPPRESSED BY M1 MUSCARINIC ANTAGONIST

      Life sciences
    29. WANG ZW; YU MF; ROBINSON NE
      PREJUNCTIONAL MUSCARINIC AUTORECEPTORS ON HORSE AIRWAY CHOLINERGIC NERVES

      Life sciences
    30. KOHLER EC; MESSER WS; BINGMAN VP
      EVIDENCE FOR MUSCARINIC ACETYLCHOLINE-RECEPTOR SUBTYPES IN THE PIGEONTELENCEPHALON

      Journal of comparative neurology
    31. DU XY; SCHOEMAKER RG; BOS E; SAXENA PR
      CHARACTERIZATION OF THE POSITIVE AND NEGATIVE INOTROPIC EFFECTS OF ACETYLCHOLINE IN THE HUMAN MYOCARDIUM

      European journal of pharmacology
    32. BELLIDO I; FERNANDEZ JL; GOMEZ A; DELACUESTA FS
      OTENZEPAD SHOWS 2 POPULATIONS OF BINDING-SITES IN HUMAN GASTRIC SMOOTH-MUSCLE

      Canadian journal of physiology and pharmacology
    33. KOW LM; TSAI YF; WEILAND NG; MCEWEN BS; PFAFF DW
      IN-VITRO ELECTROPHARMACOLOGICAL AND AUTORADIOGRAPHIC ANALYSES OF MUSCARINIC RECEPTOR SUBTYPES IN RAT HYPOTHALAMIC VENTROMEDIAL NUCLEUS - IMPLICATIONS FOR CHOLINERGIC REGULATION OF LORDOSIS

      Brain research
    34. SANCHEZ C; LEMBOL HL
      THE INVOLVEMENT OF MUSCARINIC RECEPTOR SUBTYPES IN THE MEDIATION OF HYPOTHERMIA, TREMOR, AND SALIVATION IN MALE-MICE

      Pharmacology & toxicology
    35. QUIRION R; RICHARD J; WILSON A
      MUSCARINIC AND NICOTINIC MODULATION OF CORTICAL ACETYLCHOLINE-RELEASEMONITORED BY IN-VIVO MICRODIALYSIS IN FREELY MOVING ADULT-RATS

      Synapse
    36. CEREDA E; BRAMBILLA A; EZHAYA A; GAIDA W; MENDLA K; MONFERINI E; PITSIKAS N; SCHIAVI GB; SAGRADA A
      MEDICINAL CHEMISTRY OF MUSCARINIC AGONISTS FOR THE TREATMENT OF DEMENTIA DISORDERS

      European journal of drug metabolism and pharmacokinetics
    37. CEREDA E; BRAMBILLA A; EZHAYA A; GAIDA W; MENDLA K; MONFERINI E; PITSIKAS N; SCHIAVI GB; SAGRADA A
      MEDICINAL CHEMISTRY OF MUSCARINIC AGONISTS FOR THE TREATMENT OF DEMENTIA DISORDERS

      European journal of drug metabolism and pharmacokinetics
    38. MIRANDA HF; DURAN E; BUSTAMANTE D; PAEILE C; PINARDI G
      PREJUNCTIONAL AND POSTJUNCTIONAL MUSCARINIC RECEPTOR SUBTYPES IN THE VAS-DEFERENS OF RAT

      General pharmacology
    39. PITSCHNER HF; SCHULTE B; NEUZNER J; WELLSTEIN A; PALM D; SCHLEPPER M
      SUBTYPES OF MUSCARINIC RECEPTORS - ASPECT S OF THEIR PHYSIOLOGICAL-ROLE IN THE REGULATION OF HEART-RATES IN HUMANS

      Zeitschrift fur Kardiologie
    40. CEREDA E; EZHAYA A; BELLORA E; SCHIAVI GB; SAGRADA A; DOODS HN; DONETTI A
      NEW PYRROLIDIN-2-OXOCARBOXYLIC, PIPERIDIN-2-OXOCARBOXYLIC AND AZEPIN-2-OXOCARBOXYLIC ACID-ESTERS ARE PREFERENTIAL M(1)-MUSCARINIC, M(3)-MUSCARINIC ANTAGONISTS - SYNTHESIS AND BRONCHOSPASMOLYTIC ACTIVITY

      European journal of medicinal chemistry
    41. HASHIMOTO T; SHU H; KURIYAMA K
      MUSCARINIC M(1) RECEPTOR-MEDIATED INHIBITION OF GABA RELEASE FROM RATCEREBRAL-CORTEX

      Neurochemistry international
    42. BACHOO M; POLOSA C
      LACK OF LONG-TERM POTENTIATION, NONCHOLINERGIC TRANSMISSION AND MUSCARINIC INHIBITION IN CAT SUPERIOR CERVICAL-GANGLIA INNERVATED BY NODOSEGANGLION-CELLS

      Journal of the autonomic nervous system
    43. ANTHONY TL; KREULEN DL
      A PHYSIOLOGICALLY-EVOKED M(1)-MUSCARINIC DEPOLARIZATION IN GUINEA-PIGINFERIOR MESENTERIC GANGLION NEURONS

      Journal of the autonomic nervous system
    44. BAGHDOYAN HA; CARLSON BX; ROTH MT
      PHARMACOLOGICAL CHARACTERIZATION OF MUSCARINIC CHOLINERGIC RECEPTORS IN CAT PONS AND CORTEX - PRELIMINARY-STUDY

      Pharmacology
    45. GITLER MS; DELACRUZ R; ZEEBERG BR; REBA RC
      [H-3] QNB DISPLAYS IN-VIVO SELECTIVITY FOR THE M2 SUBTYPE

      Life sciences
    46. POYER JF; GABELT BT; KAUFMAN PL
      THE EFFECT OF MUSCARINIC AGONISTS AND SELECTIVE RECEPTOR SUBTYPE ANTAGONISTS ON THE CONTRACTILE RESPONSE OF THE ISOLATED RHESUS-MONKEY CILIARY MUSCLE

      Experimental Eye Research
    47. WEIGERT N; SCHAFFER K; WEGNER U; SCHUSDZIARRA V; CLASSEN M; SCHEPP W
      FUNCTIONAL-CHARACTERIZATION OF A MUSCARINIC RECEPTOR STIMULATING GASTRIN-RELEASE FROM RABBIT ANTRAL G-CELLS IN PRIMARY CULTURE

      European journal of pharmacology
    48. DOODS HN; ENTZEROTH M; ZIEGLER H; MAYER N; HOLZER P
      PHARMACOLOGICAL PROFILE OF SELECTIVE MUSCARINIC RECEPTOR ANTAGONISTS ON GUINEA-PIG ILEAL SMOOTH-MUSCLE

      European journal of pharmacology
    49. TANIGUCHI K; TSUBAKI K; MIZUNO H; TAKE K; OKUMURA K; TERAI T; SHIOKAWA Y
      AGENTS FOR THE TREATMENT OF OVERACTIVE DETRUSOR .6. SYNTHESIS AND PHARMACOLOGICAL PROPERTIES OF ACETAMIDE DERIVATIVES BEARING CYCLIC AMINESIN N-SUBSTITUENTS

      Chemical and Pharmaceutical Bulletin
    50. OYASU H; YAMAMOTO T; SATO N; SAWADA T; OZAKI R; MUKAI T; OZAKI T; NISHII M; SATO H; FUJIWARA T; TOZUKA Z; KOIBUCHI Y; HONBO T; ESUMI K; OHTSUKA M; SHIMOMURA K
      URINARY BLADDER-SELECTIVE ACTION OF THE NEW ANTIMUSCARINIC COMPOUND VAMICAMIDE

      Arzneimittel-Forschung
    51. QUIRION R
      CHOLINERGIC MARKERS IN ALZHEIMER-DISEASE AND THE AUTOREGULATION OF ACETYLCHOLINE-RELEASE

      Journal of psychiatry & neuroscience
    52. CHRISTOPOULOS A; LOIACONO R; MITCHELSON F
      BINDING OF THE MUSCARINE RECEPTOR ANTAGONIST ANE-1,7-BIS(DIMETHYL-3'-PHTHALIMIDOPROPYL)AMMONIUM BROMIDE AT CHOLINOCEPTOR SITES

      European journal of pharmacology. Molecular pharmacology section
    53. BURGARD EC; COTE TE; SARVEY JM
      MUSCARINIC DEPRESSION OF SYNAPTIC TRANSMISSION AND BLOCKADE OF NOREPINEPHRINE-INDUCED LONG-LASTING POTENTIATION IN THE DENTATE GYRUS

      Neuroscience
    54. MARKS GA; ROFFWARG HP
      CHOLINERGIC RESPONSIVENESS OF NEURONS IN THE VENTROPOSTERIOR THALAMUSOF THE ANESTHETIZED RAT

      Neuroscience
    55. BARATTI CM; OPEZZO JW; KOPF SR
      FACILITATION OF MEMORY STORAGE BY THE ACETYLCHOLINE-M(2) MUSCARINIC RECEPTOR ANTAGONIST-AF-DX-116

      Behavioral and neural biology
    56. GITLER MS; COHEN VI; DELACRUZ R; BOULAY SF; JIN BY; ZEEBERG BR; REBA RC
      A NOVEL MUSCARINIC RECEPTOR-LIGAND WHICH PENETRATES THE BLOOD-BRAIN-BARRIER AND DISPLAYS IN-VIVO SELECTIVITY FOR THE M2 SUBTYPE

      Life sciences
    57. DOODS H; ENTZEROTH M; ZIEGLER H; SCHIAVI G; ENGEL W; MIHM G; RUDOLF K; EBERLEIN W
      CHARACTERIZATION OF BIBN-99 - A LIPOPHILIC AND SELECTIVE MUSCARINIC M(2)-RECEPTOR ANTAGONIST

      European journal of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/01/21 alle ore 19:55:02